People with metabolic dysfunction-associated steatotic liver disease (MASLD) worldwide in 2021

1.27 billion

people, worldwide

“In 2021, MASLD had a prevalence of 1.27 billion people”

Danpanichkul et al., The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021), United European Gastroenterol J 2025, 2025-09

Kind of source
Peer-reviewed study
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
GBD 2021 modelled count. GBD reports this condition under its older name NAFLD; the paper calls it MASLD.

Used in

Kept as evidence; no figure on the platform is computed from it yet.